181 related articles for article (PubMed ID: 26225729)
21. Inflammation in atherosclerosis.
Taleb S
Arch Cardiovasc Dis; 2016 Dec; 109(12):708-715. PubMed ID: 27595467
[TBL] [Abstract][Full Text] [Related]
22. B cells and atherosclerosis.
Srikakulapu P; McNamara CA
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H1060-H1067. PubMed ID: 28314764
[TBL] [Abstract][Full Text] [Related]
23. Monocyte subsets in atherosclerosis.
Hristov M; Heine GH
Hamostaseologie; 2015; 35(2):105-12. PubMed ID: 25396218
[TBL] [Abstract][Full Text] [Related]
24. Immunometabolism of AMPK in insulin resistance and atherosclerosis.
Fullerton MD; Steinberg GR; Schertzer JD
Mol Cell Endocrinol; 2013 Feb; 366(2):224-34. PubMed ID: 22361321
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulation of the inflammatory response in atherosclerosis.
Kuiper J; van Puijvelde GH; van Wanrooij EJ; van Es T; Habets K; Hauer AD; van den Berkel TJ
Curr Opin Lipidol; 2007 Oct; 18(5):521-6. PubMed ID: 17885422
[TBL] [Abstract][Full Text] [Related]
26. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
Caesar R; Fåk F; Bäckhed F
J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils in atherosclerosis. A brief overview.
Hartwig H; Silvestre Roig C; Daemen M; Lutgens E; Soehnlein O
Hamostaseologie; 2015; 35(2):121-7. PubMed ID: 25385255
[TBL] [Abstract][Full Text] [Related]
28. Innate Immunity in Coronary Disease. The Role of Interleukin-12 Cytokine Family in Atherosclerosis.
Posadas-Sánchez R; Vargas-Alarcón G
Rev Invest Clin; 2018; 70(1):5-17. PubMed ID: 29513302
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
30. Atherothrombotic risk in obesity.
Badimon L; Hernández Vera R; Vilahur G
Hamostaseologie; 2013; 33(4):259-68. PubMed ID: 24190286
[TBL] [Abstract][Full Text] [Related]
31. Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis.
Mangge H; Hubmann H; Pilz S; Schauenstein K; Renner W; März W
Clin Chem Lab Med; 2004 May; 42(5):467-74. PubMed ID: 15202781
[TBL] [Abstract][Full Text] [Related]
32. Immunopathology of Adipose Tissue during Metabolic Syndrome.
Ghazarian M; Luck H; Revelo XS; Winer S; Winer DA
Turk Patoloji Derg; 2015; 31 Suppl 1():172-80. PubMed ID: 26177326
[TBL] [Abstract][Full Text] [Related]
33. The role of inflammatory cytokines in diabetes and its complications.
King GL
J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
[TBL] [Abstract][Full Text] [Related]
34. Atherogenesis and inflammation. From cellular mediators to regulatory mechanisms of inflammation in atherosclerosis.
Weber C; Hristov M
Hamostaseologie; 2015; 35(2):99, 101. PubMed ID: 25943077
[No Abstract] [Full Text] [Related]
35. Lymphocytic tumor necrosis factor receptor superfamily co-stimulatory molecules in the pathogenesis of atherosclerosis.
Smeets E; Meiler S; Lutgens E
Curr Opin Lipidol; 2013 Dec; 24(6):518-24. PubMed ID: 24184937
[TBL] [Abstract][Full Text] [Related]
36. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
[TBL] [Abstract][Full Text] [Related]
37. Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.
Sorrentino R; Arditi M
Methods Mol Biol; 2009; 517():381-99. PubMed ID: 19378021
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
Steinman L
Sci Signal; 2013 Jan; 6(258):pe3. PubMed ID: 23322904
[TBL] [Abstract][Full Text] [Related]
39. The Role of Cytokines in the Development of Atherosclerosis.
Fatkhullina AR; Peshkova IO; Koltsova EK
Biochemistry (Mosc); 2016 Nov; 81(11):1358-1370. PubMed ID: 27914461
[TBL] [Abstract][Full Text] [Related]
40. When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors.
Palano MT; Cucchiara M; Gallazzi M; Riccio F; Mortara L; Gensini GF; Spinetti G; Ambrosio G; Bruno A
Front Immunol; 2021; 12():798155. PubMed ID: 35095876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
